US-based developer, manufacturer and distributor of continuous glucose monitoring systems, Dexcom has opened its Europe, Middle East and Africa (EMEA) headquarters in Edinburgh, Scotland.

The new office will support various Dexcom business functions for EMEA while generating more than 60 new jobs for the region in the next three years.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

It will be supported by the Scottish Enterprise and will serve as the platform to distribute Dexcom’s suite of Mobile CGM Systems into EMEA markets.

"With exceptional strengths in both life sciences and digital technologies, Scotland is the ideal location for Dexcom’s European headquarters."

Scottish Development International managing director Paul Lewis said: “With exceptional strengths in both life sciences and digital technologies, Scotland is the ideal location for Dexcom’s European headquarters.

“The company will now join the many international investors who benefit from our competitive business environment, strong skills base and effective support network, which help make Scotland the top performing location for inward investment after London.

“We look forward to supporting Dexcom’s ambitious growth plans for Europe, the Middle-East and Africa.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The new office will open access for the patients across the EMEA regions to Dexcom’s products such as CGM sensor that is fitted below the skin's surface and is attached to a transmitter which wirelessly transfers real-time glucose levels after every five minutes to mobile applications through Bluetooth.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact